论文部分内容阅读
上市造假事件屡禁不止,合理的惩罚力度应该是让其承受不了造假的后果创业板财务爆出造假第一股。2011年9月登陆创业板的万福生科,一年之后被证监会正式立案调查。今年3月,万福生科公告,承认其在2008年至2011年累计虚增收入近7.4亿元、虚增营业利润1.8亿元左右、虚增净利润1.6亿元左右。通过财务造假,万福生科获得创业板上市资格;其后一年间,该公司虚增营业收入1.88亿元、营业成本1.46
Repeatedly prohibit the listing of counterfeit events, a reasonable punishment should be so that it can not stand the consequences of false financial GEM broke the first wave of shares. In September 2011, Vanuatu, who landed the GEM, was formally investigated by the CSRC one year later. In March of this year, Wanfo Health Sciences Bulletin acknowledged that its accumulated inflated revenue from 2008 to 2011 was nearly 740 million yuan, inflated operating profit of 180 million yuan and inflated net profit of 160 million yuan. Through financial fraud, Wanfu Shengke GEM access to listed qualifications; the following year, the company inflated revenue of 188 million yuan, operating costs 1.46